Why FitBit won't work with HealthKit

Laura Pedulli | | Health Exec | Digital Transformation

FitBit will remain imcompatible with Apple's HealthKit for the simple reason that it plans to launch its own wearable device that will compete directly with Apple Watch, according to Tech Crunch.

FitBit soon will unveil its FitBit Surge, a $250 wearable with a watch-like display, built-in GPS tracking and heart-rate monitoring that will move Fitbit beyond its existing step-based activity tracking.

Read more below:

Fitbit Won’t Work With HealthKit Because It’s Building An Apple Watch Competitor

Laura Pedulli

Related Content

2024 in AI weirdness: ‘Insane’ ChatGPT and mutant rat genitals were only the beginning
10 signs AI is ‘eating the world (of venture capital)’
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.